Mal-PEG8-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a maleimide PEG8 moiety, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. Mal is reactive with thiol group of antibody. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.
Usually ships within 24 hours.